| Line Item | 2026-04-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $276.7M | — | +20.8% |
| Cost of Revenue | $78.0M | — | +37.9% |
| Gross Profit | $198.7M | — | +15.2% |
| R&D Expense | $95.8M | — | +32.5% |
| SG&A Expense | $50.5M | — | +3.7% |
| Operating Income | -$79.7M | — | +8.9% |
| Pre-tax Income | -$70.4M | — |
| Line Item | 2026-04-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $153.2M | -9.7% | -18.8% |
| Short-term Investments | $503.6M | +9.7% | -12.9% |
| Accounts Receivable | $180.7M | -37.5% | +16.6% |
| Current Assets | $965.9M | -8.1% | -6.3% |
| Total Assets | $2.36B | -3.4% | -1.2% |
| Current Liabilities |
| Line Item | 2026-04-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $38.5M | — | -26.4% |
| Capital Expenditures | $424K | — | +190.4% |
| Investing Cash Flow | -$63.9M | — | +2.6% |
| Financing Cash Flow | $882K | — | -92.8% |
| Free Cash Flow | $38.1M | — | -27.0% |
| +5.8% |
| Income Tax | $5.8M | — | -95.7% |
| Net Income | -$76.2M | — | +63.4% |
| EPS (Basic) | -$0.23 | — | +63.5% |
| EPS (Diluted) | -$0.23 | — | +63.5% |
| $672.3M |
| -11.1% |
| +14.2% |
| Total Liabilities | $918.2M | -8.3% | +9.6% |
| Stockholders' Equity | $1.44B | +0.1% | -7.0% |